Literature DB >> 7639414

Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits. An experimental model for Kawasaki disease in humans.

Z Onouchi1, K Ikuta, K Nagamatsu, H Tamiya, Y Sakakibara, M Ando.   

Abstract

The involvement of the cardiovascular system in rabbits with serum sickness is similar of that in Kawasaki disease, both with respect to the histologic changes of the myocardium, the valves, the coronary arteries, and the aorta and to the sequence with which they appear. Although coronary arteritis appears the same histologically, aneurysms did not occur in mature rabbits, even in case of necrosis of an arterial segment with deletion of muscle and elastic tissue. On the other hand, weanling rabbits with serum sickness had a tendency to develop aneurysms of coronary arteries, despite little cellular infiltration and reactive fibrocellular hyperplasia. The age factor thus appears to play an important role in the development of coronary aneurysms in Kawasaki disease, irrespective of the underlying mechanism, be it a markedly increased permeability to mediators through degenerated endothelial cells, or primary degenerated muscle cells with marked thinning of the media without much inflammatory cellular reaction. Furthermore, this study provides an insight into the long-term prognosis of transient dilatation of coronary arteries in the acute stage of Kawasaki disease.

Entities:  

Mesh:

Year:  1995        PMID: 7639414     DOI: 10.1177/000331979504600806

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  10 in total

Review 1.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

2.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 3.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

4.  [Value of ginsenoside Rb1 in alleviating coronary artery lesion in a mouse model of Kawasaki disease].

Authors:  Shuang-Hui Qi; Feng Xiao; Bing Wei; Can Qin
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

5.  Immune vasculitis induced atherosclerosis.

Authors:  Min Kang; Hongwei Wang; Weizhong Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

6.  Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.

Authors:  I-Chun Lin; Ho-Chang Kuo; Ying-Jui Lin; Feng-Shen Wang; Lin Wang; Shun-Chen Huang; Shao-Ju Chien; Chien-Fu Huang; Chih-Lu Wang; Hong-Ren Yu; Rong-Fu Chen; Kuender D Yang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

7.  Histopathological Characteristics of Post-inflamed Coronary Arteries in Kawasaki Disease-like Vasculitis of Rabbits.

Authors:  Maiko Fujii; Hideo Tanaka; Akihiro Nakamura; Chinatsu Suzuki; Yoshinori Harada; Tetsuro Takamatsu; Kenji Hamaoka
Journal:  Acta Histochem Cytochem       Date:  2016-01-22       Impact factor: 1.938

8.  Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune Vasculitis.

Authors:  Hui Chen; Huiying Shu; Weiqing Su; Bo Li; Hua Zhang; Liang Li; Chao Lin; Wenfang Yi; Xiao-Yong Zhan; Chun Chen; Xiaojing Li; Yanqi Yang; Min Zhou; Mo Yang
Journal:  Front Cardiovasc Med       Date:  2022-04-13

9.  Role of the PTEN/PI3K/VEGF pathway in the development of Kawasaki disease.

Authors:  Xinjiang An; Haitao Lv; Jing Tian; Xiuhua He; Nan Ling
Journal:  Exp Ther Med       Date:  2016-01-27       Impact factor: 2.447

Review 10.  Recent Advances in Kawasaki Disease.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.